|Go to market news section|
CRIMSON TIDE PLC
("Crimson Tide" or "the Company")
SIGNIFICANT MPRO5 SUBSCRIPTION CONTRACT WIN IN THE NETHERLANDS
Crimson Tide (TIDE), the AIM-quoted provider of mpro5 - Smart Mobile Working, has secured a long term contract in The Netherlands with one of the world's largest facilities management companies.
The contract is worth a minimum of €200,000 with the potential to rise to a maximum of over €1m and is for a 48 month period
The client will use mpro5 for mobile scheduling, reporting and auditing of workflow and activities. Users of mpro5's enterprise mobile solutions pay a monthly subscription for software, cloud infrastructure, installation and all services required by their out-of-office teams. This makes for easy initial adoption, often followed by wider internal take-up as the performance benefits are established.
Barrie Whipp, Executive Chairman, commented: "We have been making a number of strategic growth investments internationally and this contract represents an excellent foundation for our expansion in Northern Europe. mpro5 is well positioned for organisations that have larger geographic footprints which, with our Microsoft Azure Cloud infrastructure, we are able to support."
Crimson Tide plc, Barrie Whipp - 01892 542 444
WH Ireland Limited, James Joyce / James Bavister - 020 7220 1666
Notes to editors Founded in 1996 and quoted on AIM since 2006, Crimson Tide plc is the provider of mpro5 - Smart Mobile Working. mpro5 is delivered on smartphones, tablets and PDAs, and enables companies to transform their businesses and strengthen their workforces. Crimson Tide offers a global service, working with some of the world's leading companies, tailoring mpro5 to suit customer needs. Developed over 10 years by its world-class team, mpro5 is the smart choice for organisations large and small that want to improve productivity and save money. mpro5 is a platform-agnostic mobility suite fully hosted on Microsoft Azure, so customers are quickly up and running and the service is scalable and robust. It is provided on subscription, so clients can immediately see a return on their investment. mpro5 not only helps people improve their day-to-day working methods while saving employers money, it also saves lives, by enabling haemophilia patients to verify the safety of their medication before use. mpro5 clients come from a diverse range of industries allowing the Company to listen, share and find the best solution for all mobility needs.
The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.
|©London Stock Exchange plc. All rights reserved|